Benzinga's Top Pre-Market NASDAQ Gainers (ITMN, YRCW, TTWO, ORCL)

InterMune Inc ITMN rose 121.37% to $31.59 in the pre-market session. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has backed the ITMN's experimental lung drug Esbriet. YRC Worldwide Inc YRCW added 8.38% to $3.62 in the pre-market session. YRCW's shares have dipped 85.79% over the past 52 weeks, while the S&P 500 index has gained 13.39% in the same period. Take-Two Interactive Software Inc TTWO moved up 6.78% to $12.75 in the pre-market session. TTWO swung to a Q4 profit of $0.58 per share, from a loss of $0.30 per share, in the year-ago quarter. Oracle Corp ORCL soared 4.69% to $31.69 in the pre-market trading. ORCL reported 47% y/y surge in its FQ2 revenue. Read more from Benzinga's Markets.